| Trial ID: | L0854 |
| Source ID: | NCT01209403
|
| Associated Drug: |
Glucose-Infusion
|
| Title: |
Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: Glucose-infusion|DRUG: Glucose-insulin infusion
|
| Outcome Measures: |
Primary: Effect of glucose and glucose-insulin infusion on plasma IGF-I and IGFBP-1 during hemodialysis, All patients are randomly assigned to a hemodialysis session with either i) no infusion, ii) a continuous iv infusion of glucose, and iii) a continuous iv infusion of glucose and shortacting insulin. Each dialysis session will be separated by 2 weeks of wash-out, From 2 h prior to start of hemodialysis to 2 h after end of hemodialysis | Secondary: Relationship between inflammatory markers and plasma concentrations of IGF-I and IGFBP-1 during hemodialysis, From 2 h prior to start of hemodialysis to 2 h after end of hemodialysis
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-09
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2011-09-30
|
| Locations: |
Department of Nephrology, Aarhus University Hospital, Skejby, Aarhus, 8200 N, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01209403
|
